SequelSEC

PURE BIOSCIENCE, INC. PURE

Miscellaneous Chemical Products · CIK 0001006028 · Fiscal year ends 0731

Revenue
$2.32M
Fiscal year ended 2026-07-31
Operating income
-$2.08M
Fiscal year ended 2026-07-31
Free cash flow
Unavailable
Fiscal year ended 2026-07-31

Valuation, from the filing

Public float$4.67MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-01-31
Float per share$0.04Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue2.1×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-01-31, not today, and each multiple below it uses the figures for the fiscal year ending 2025-07-31 — the year that filing covered.

How this compares in its industry

Percentile among the Miscellaneous Chemical Products filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Gross margin57.3%100th
Net margin-107.3%12th
Operating margin-90.0%12th
R&D / revenue14.3%88th
SBC / revenue8.5%88th
Current ratio0.27x25th
Revenue YoY growth5.3%75th

PURE BIOSCIENCE, INC. (PURE) reported revenue of $2.32M and net income of -$2.48M for the fiscal year ended 2026-07-31. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from PURE BIOSCIENCE, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Miscellaneous Chemical Products.

Income

PURE BIOSCIENCE, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-31
Revenue$2.32M
Cost of revenue$992.00K
Gross profit$1.33M
Operating income-$2.08M
Net income-$2.48M
Research & development$332.00K
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$3.08M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

PURE BIOSCIENCE, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-31
Cash & equivalents$569.00K
Total assets$1.19M
Current assets$1.18M
Total liabilities$7.59M
Current liabilities$4.37M
Total equity incl. NCI-$6.40M
Temporary (mezzanine) equityUnavailable
Inventory$193.00K
Accounts receivable$334.00K
GoodwillUnavailable
Long-term debt$6.60M
Accounts payable$820.00K

Cash flow

PURE BIOSCIENCE, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-31
Operating cash flow-$1.74M
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$1.97M
Net change in cash$235.00K
Stock-based compensation$197.00K
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

PURE BIOSCIENCE, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-31
Free cash flowUnavailable
Gross margin57.3%
Operating margin-90.0%
FCF marginUnavailable
SBC / revenue8.5%
Current ratio0.27x
Revenue YoY growth5.3%
Net margin-107.3%
R&D / revenue14.3%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open PURE in the interactive workspace to inspect any figure back to its filing.

Source filings

10-K · Filed 2026-10-29View SEC filing
10-Q · Filed 2026-06-15View SEC filing
10-Q · Filed 2026-03-17View SEC filing
10-Q · Filed 2025-12-15View SEC filing
10-K · Filed 2025-10-29View SEC filing
10-Q · Filed 2025-06-16View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.